申请人:Merck & Co., Inc.
公开号:US04530841A1
公开(公告)日:1985-07-23
Disclosed are 6- and 6,6-disubstituted-3-substituted amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acids (I): ##STR1## wherein R.sup.1 and R.sup.2 are, inter alia, independently selected from the group consisting of hydrogen, substituted and unsubstituted: alkyl, aryl, and aralkyl; and R' and R" are independently selected from the group consisting of: H, substituted and unsubstituted alkyl and aralkyl, or together form a substituted or unsubstituted cyclic group. Such compounds and their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering compounds and compositions when an antibiotic effect is indicated.
揭示了6-和6,6-二取代-3-取代氨基-1-氮杂双环[3.2.0]庚-2-烯-7-酮-2-羧酸(I):其中R.sup.1和R.sup.2等可独立地选择自氢、取代和未取代的烷基、芳基和芳基甲基等组成的群;R'和R"等可独立地选择自H、取代和未取代的烷基和芳基甲基,或者一起形成取代或未取代的环状基团。这类化合物及其药学上可接受的盐、酯和酰胺衍生物可用作抗生素。还公开了制备这类化合物的方法、包含这类化合物的药物组合物以及在需要抗生素效果时给予化合物和组合物的治疗方法。